Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising

September 17, 2020

Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising

Phase III trials of a COVID-19 vaccine developed by China's Sinovac Biotech Ltd have thus far demonstrated promising results, with the vaccine potentially available commercially by December. According to Sao Paulo’s Governor Joao Doria, 98 percent of elderly people dosed generated an immune response. Approximately 9,000 people are participating in the trial. Yourway has a local depot located in Sao Paulo with over 10,000 square feet of capacity with storage temperatures of up to -20 degrees Celsius.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat

Hello! How can I help you?